<html xmlns:v="urn:schemas-microsoft-com:vml"
      xmlns:o="urn:schemas-microsoft-com:office:office"
      xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 9">
<meta name=Originator content="Microsoft Word 9">
<link rel=File-List href="./Page3_files/filelist.xml">
<link rel=Edit-Time-Data href="./Page3_files/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]-->
<title> </title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>jennifer</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>jennifer</o:LastAuthor>
  <o:Revision>9</o:Revision>
  <o:TotalTime>224</o:TotalTime>
  <o:Created>2004-07-27T11:41:00Z</o:Created>
  <o:LastSaved>2004-08-02T17:29:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>694</o:Words>
  <o:Characters>3956</o:Characters>
  <o:Company>EMBL-EBI</o:Company>
  <o:Lines>32</o:Lines>
  <o:Paragraphs>7</o:Paragraphs>
  <o:CharactersWithSpaces>4858</o:CharactersWithSpaces>
  <o:Version>9.4402</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:Zoom>75</w:Zoom>
  <w:DrawingGridHorizontalSpacing>6 pt</w:DrawingGridHorizontalSpacing>
  <w:DisplayHorizontalDrawingGridEvery>2</w:DisplayHorizontalDrawingGridEvery>
  <w:DisplayVerticalDrawingGridEvery>2</w:DisplayVerticalDrawingGridEvery>
 </w:WordDocument>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
 /* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:3.0pt;
	margin-left:0cm;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:16.0pt;
	font-family:Arial;
	mso-font-kerning:16.0pt;}
h2
	{mso-style-next:Normal;
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:14.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:Arial;
	color:navy;
	font-weight:normal;
	font-style:italic;}
a:link, span.MsoHyperlink
	{color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{color:purple;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:595.3pt 841.9pt;
	margin:72.0pt 89.85pt 72.0pt 89.85pt;
	mso-header-margin:35.45pt;
	mso-footer-margin:35.45pt;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
 /* List Definitions */
@list l0
	{mso-list-id:1527214020;
	mso-list-type:hybrid;
	mso-list-template-ids:-602632212 67698699 67698691 67698693 67698689 67698691 67698693 67698689 67698691 67698693;}
@list l0:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0D8;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>
<!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1033"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-GB link=blue vlink=purple style='tab-interval:36.0pt'>

<div class=Section1>

<p class=MsoNormal>-<a href="http://www.ebi.ac.uk/interpro/"
title="To the InterPro database"><span style='color:windowtext;text-decoration:
none;text-underline:none'><!--[if gte vml 1]><v:shapetype id="_x0000_t75"
 coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe"
 filled="f" stroked="f">
 <v:stroke joinstyle="miter"/>
 <v:formulas>
  <v:f eqn="if lineDrawn pixelLineWidth 0"/>
  <v:f eqn="sum @0 1 0"/>
  <v:f eqn="sum 0 0 @1"/>
  <v:f eqn="prod @2 1 2"/>
  <v:f eqn="prod @3 21600 pixelWidth"/>
  <v:f eqn="prod @3 21600 pixelHeight"/>
  <v:f eqn="sum @0 0 1"/>
  <v:f eqn="prod @6 1 2"/>
  <v:f eqn="prod @7 21600 pixelWidth"/>
  <v:f eqn="sum @8 21600 0"/>
  <v:f eqn="prod @7 21600 pixelHeight"/>
  <v:f eqn="sum @10 21600 0"/>
 </v:formulas>
 <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
 <o:lock v:ext="edit" aspectratio="t"/>
</v:shapetype><v:shape id="_x0000_i1025" type="#_x0000_t75" style='width:113.25pt;
 height:36.75pt'>
 <v:imagedata src="./Page3_files/image001.jpg" o:title="InterPro_logo"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=151 height=49
src="./Page3_files/image001.jpg" v:shapes="_x0000_i1025"><![endif]></span></a></p>

<h1 align=center style='text-align:center'><span style='font-size:28.0pt;
mso-bidi-font-size:16.0pt;color:navy'>Caspases<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span style='color:navy'>The Domains of Apoptosis<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>The many,
diverse apoptosis proteins found in higher organisms allow for tissue-specific
mechanisms that enable the precise regulation of cell survival , whereby
specific members of apoptotic gene families are expressed at certain times in
development.<span style="mso-spacerun: yes">  </span>Post-translational
modifications and protein-interaction networks add further fine-tuning of
life-span regulation.<span style="mso-spacerun: yes">  </span>Yet the domains
associated with the core apoptotic proteins are highly conserved throughout
animal species.<span style="mso-spacerun: yes">  </span>Domains such as CARD (<a
href="http://www.ebi.ac.uk/interpro/IEntry?ac=IPR001315"
title="InterPro entry for the CARD domain">IPR001315</a>), Death (DD) (<a
href="http://www.ebi.ac.uk/interpro/DisplayIproEntry?ac=IPR000488"
title="InterPro entry for the Death domain">IPR000488</a>), Death effector
(DED) (<a href="http://www.ebi.ac.uk/interpro/IEntry?ac=IPR001875"
title="InterPro entry for the Death effector domain">IPR001875</a>) and
Dapin/Pyrin (<a
href="http://www.ebi.ac.uk/interpro/DisplayIproEntry?ac=IPR004020"
title="InterPro entry for the Dapin/Pyrin domain">IPR004020</a>) act as
interaction motifs that promote interactions with proteins containing the same
domains, for instance CARD-CARD interactions.<span style="mso-spacerun: yes"> 
</span>In this way, proteins can specifically target certain proteins within a
pathway without the problem of cross-reactivity.<span style="mso-spacerun:
yes">  </span>Within a single protein, these domains can occur in combination
with other interaction domains, permitting a specific sequence of events, or
enabling the assembly of multi-protein complexes.<span style="mso-spacerun:
yes">  </span>For example, the Apaf-1 protein that is critical for forming the
Apaf1/cyt c/caspase-9 apoptosome contains a CARD domain to bind to the
CARD-containing caspase-9, a series of WD repeat domains to bind to cytochrome
C, and a NB-ARC domain to allow Apaf1 to oligomerise into a heptamer.<span
style="mso-spacerun: yes">  </span>The assembly of the apoptosome provides a
scaffold upon which the protease can act.<span style="mso-spacerun: yes"> 
</span></p>

<p class=MsoNormal style='text-indent:36.0pt'>Other conserved domains that
participate in apoptosis include:<span style="mso-spacerun: yes">  </span>the
nucleotide-binding NACHT (<a
href="http://www.ebi.ac.uk/interpro/DisplayIproEntry?ac=IPR007111"
title="InterPro entry for the NACHT domain">IPR007111</a>) and NB-ARC domains (<a
href="http://www.ebi.ac.uk/interpro/IEntry?ac=IPR002182"
title="InterPro entry for the NB-ARC domain">IPR002182</a>), which provide
NTPase activity and promote oligomerization; Leucine-rich repeat (LRR) domains
(<a href="http://www.ebi.ac.uk/interpro/IEntry?ac=IPR001611"
title="InterPro entry for the Leucine-Rich Repeat domain">IPR001611</a>), which
may recognise pathogen-derived molecules; PDZ (<a
href="http://www.ebi.ac.uk/interpro/IEntry?ac=IPR001478"
title="InterPro entry for PDZ domains">IPR001478</a>), WD repeat (<a
href="http://www.ebi.ac.uk/interpro/IEntry?ac=IPR001680"
title="InterPro entry for WD repeats">IPR001680</a>) and CIDE domains (<a
href="http://www.ebi.ac.uk/interpro/DisplayIproEntry?ac=IPR003508"
title="InterPro entry for the CIDE domain">IPR003508</a>), which mediate
protein-protein interactions; and the zinc-binding BIR domains (<a
href="http://www.ebi.ac.uk/interpro/DisplayIproEntry?ac=IPR001370"
title="InterPro entry for the BIR domain">IPR001370</a>), which occur in the
inhibitor of apoptosis (IAP) proteins.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1><span style='color:navy'>Caspase Domain Architecture<o:p></o:p></span></h1>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><span style='mso-tab-count:1'>            </span>Caspases
are composed of an N-terminal pro-domain that is cleaved during activation, and
C-terminal catalytic and interaction domains.<span style="mso-spacerun: yes"> 
</span>All caspases contain two essential caspase catalytic domains:<span
style="mso-spacerun: yes">  </span>the p10 subunit (<a
href="http://www.ebi.ac.uk/interpro/IEntry?ac=IPR002138"
title="InterPro entry for caspase p10 subunit">IPR002138</a>), and the p20
subunit (<a href="http://www.ebi.ac.uk/interpro/IEntry?ac=IPR001309"
title="InterPro entry for caspase p20 subunit">IPR001309</a>), the latter
containing the key catalytic residues cysteine and histidine.<span
style="mso-spacerun: yes">  </span>Human caspases can be divided into three
groups based on their domain architecture, which are depicted below using the
InterPro Domain Architecture tool:</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt;mso-list:l0 level1 lfo2;
tab-stops:list 36.0pt'><![if !supportLists]><span style='font-family:Wingdings'>Ø<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><![endif]>Those
that only contain catalytic domains p10 and p20 are generally downstream
effector caspases, such as caspases-3, -6, -7 and –14.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><!--[if gte vml 1]><v:shape id="_x0000_i1026" type="#_x0000_t75"
 style='width:150pt;height:30pt'>
 <v:imagedata src="./Page3_files/image002.png" o:title="IDA2"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=200 height=40
src="./Page3_files/image003.jpg" v:shapes="_x0000_i1026"><![endif]></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt;mso-list:l0 level1 lfo2;
tab-stops:list 36.0pt'><![if !supportLists]><span style='font-family:Wingdings'>Ø<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><![endif]>Those
that contain a tandem pair of DED (Death effector domain) domains are initiator
caspases, such as caspases-8 and –10.<span style="mso-spacerun: yes"> 
</span>These caspases interact with the DED domain in FADD, which is itself
attached to the TNF cell surface receptor through DD-DD domain (Death domain)
interactions.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><!--[if gte vml 1]><v:shape id="_x0000_i1027" type="#_x0000_t75"
 style='width:225pt;height:30pt'>
 <v:imagedata src="./Page3_files/image004.png" o:title="IDA3_2"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=300 height=40
src="./Page3_files/image005.jpg" v:shapes="_x0000_i1027"><![endif]></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal style='margin-left:36.0pt;text-indent:-18.0pt;mso-list:l0 level1 lfo2;
tab-stops:list 36.0pt'><![if !supportLists]><span style='font-family:Wingdings'>Ø<span
style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span><![endif]>Those
that contain a CARD domain are either initiator caspases involved in the intrinsic
pathway, caspases-2 (Golgi) and –9 (mitochondria), or those involved in
activating pro-inflammatory cytokines, caspases-1, -4 and –5.<span
style="mso-spacerun: yes">  </span>The CARD domains are involved in
protein-protein interactions via CARD-CARD coupling.</p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<p class=MsoNormal><!--[if gte vml 1]><v:shape id="_x0000_i1028" type="#_x0000_t75"
 style='width:225pt;height:30pt'>
 <v:imagedata src="./Page3_files/image006.png" o:title="IDA1"/>
</v:shape><![endif]--><![if !vml]><img border=0 width=300 height=40
src="./Page3_files/image007.jpg" v:shapes="_x0000_i1028"><![endif]></p>

<p class=MsoNormal><![if !supportEmptyParas]>&nbsp;<![endif]><o:p></o:p></p>

<h1 align=center style='text-align:center'>Next:<span style="mso-spacerun:
yes">  </span><a href="Page4.htm" title="Next page">What InterPro Tells Us</a></h1>

<h1 align=center style='text-align:center'>Previous:<span style="mso-spacerun:
yes">  </span><a href="Page2.htm" title="Previous page">What Makes a Cell
Commit Suicide</a></h1>

</div>

</body>

</html>
